How Scientists Grow Nature's Pharmacy in the Lab
Lichens are symbiotic associations between a fungus (the mycobiont) and a photosynthetic partner (the photobiont), which is either an alga or a cyanobacterium 1 . The fungal partner provides structure and protection, while the photosynthetic partner produces food through photosynthesis. This partnership is so successful that lichens cover about 8% of the Earth's surface, thriving in places where most other organisms cannot survive, from arctic tundras to hot deserts 1 .
Many compounds have antibacterial, antiviral, antifungal, and anticancer properties 1
Directly harvesting compounds from wild lichens is neither practical nor sustainable. Many lichen species grow extremely slowly, and large-scale collection could threaten their survival. This challenge has driven scientists to develop methods for cultivating lichens in the laboratory, allowing them to study and potentially harness these valuable compounds without damaging natural populations.
Cultivating lichens in the laboratory has been described as a "serious handicap" that has limited progress in understanding their biology and exploiting their chemical wealth 1 . The difficulty lies in recreating the complex symbiotic relationship and environmental conditions that lichens require to thrive and produce their secondary metabolites.
Researchers have found that the ability of lichen-forming fungi from the same genus to flourish in different ecological environments represents a significant challenge for standardizing cultivation methods 1 . This means that protocols often need to be customized for specific species, making the process time-consuming and labor-intensive.
The term "morphogenesis" refers to the biological process that causes an organism to develop its shape. In lichenology, understanding morphogenesis means understanding how the fungal and algal partners come together to form the specific structure of the lichen thallus (the main body of the lichen).
A key insight in this field is that lichen-forming fungi only express their symbiotic phenotype—producing thalli with species-specific features—when associated with a compatible photobiont 6 . Approximately 85% of lichen mycobionts partner with green algae, about 10% with cyanobacteria, and 3-4% form simultaneous associations with both 6 .
The fungal hyphae must locate and incorporate appropriate algal cells.
Fungal hyphae begin to envelop the algal cells.
The fungus develops protective outer layers.
The characteristic forms of the lichen thallus emerge.
Researchers have discovered that specific culture conditions can influence these morphogenetic processes, potentially guiding the development of lichens in laboratory settings to enhance the production of desired secondary metabolites.
(formerly Cladia retipora)
Commonly known as coral lichen or lace lichen, this species is particularly notable for its intricate, netlike perforations 4 . It was first collected in 1792 and holds the distinction of being the first Australian lichen to be scientifically documented 4 .
The concentration of usnic acid determines the lichen's color, which can range from opaque greyish-white to distinct yellow 4 .
Arctic Butterfingers lichen
Known as the Arctic Butterfingers lichen, this species represents another important model for studying lichen cultivation and secondary metabolite production 3 . While detailed information about its specific chemistry is less extensively documented in the search results, it has been used alongside P. retipora in studies exploring morphogenetic strategies and the induction of secondary metabolite biosynthesis 3 7 .
The first critical step in lichen cultivation is isolating the fungal partner (mycobiont). Researchers have developed several approaches for this process:
Method | Description | Success Rate | Contamination Risk |
---|---|---|---|
Ascospore Discharge | Mature ascomata attached to petri dish lids discharge spores onto agar medium 1 | 53% of species successfully isolated this way 1 | Low (15% contamination rate) 5 |
Thallus Fragments | Thallus homogenized and filtered through meshes, then inoculated onto culture medium 1 | Used for 38 species, including those that don't produce ascomata 1 | Higher due to associated microorganisms |
Soredia Isolation | Using asexual reproductive structures containing both fungal and algal cells 5 | Successful for Cladonia species 5 | Moderate |
According to recent research, the ascospore discharge method has proven particularly effective, with spores of some species discharging within just two days and germinating within four days 5 . All samples with discharged spores developed colonies within 30 days 5 .
For species that don't produce ascocarps (fruiting bodies), the soredia and thallus methods without homogenization have shown good results for obtaining pure fungal cultures 5 .
Once isolated, the challenge becomes inducing the mycobiont to produce the valuable secondary metabolites it would normally only create in its natural symbiotic relationship. The featured research by Stocker-Wörgötter and Elix explored various strategies to trigger this biosynthesis in P. retipora and D. arctica 3 7 .
Carefully controlling carbon and nitrogen sources in the culture media to simulate natural conditions and stress factors.
Applying controlled variations in temperature, light intensity, photoperiod, and UV radiation to mimic natural environmental fluctuations.
Reintroducing the photobiont to the mycobiont under controlled conditions to reestablish aspects of the symbiotic relationship.
The research demonstrated that physicochemical in vitro conditions significantly influence secondary metabolite production in lichens 1 . Parameters such as temperature, photoperiod, pH, UV radiation, and humidity all play crucial roles in activating the biosynthetic pathways.
Factor | Effect on Metabolite Production |
---|---|
Temperature Fluctuations | Simulates natural day-night cycles, triggering defense mechanisms |
UV Radiation | Induces protective compound synthesis |
Nutrient Stress | Limited nutrients may activate secondary metabolic pathways |
Photoperiod | Mimics seasonal changes, influencing metabolic cycles |
Moisture Variations | Recreates natural hydration cycles, affecting metabolic activity |
Successful lichen cultivation requires carefully selected materials and reagents. Here are some key components used in these experiments:
The systematic approach to culturing lichen-forming fungi has yielded promising results. Researchers have successfully cultivated 110 species from 11 orders, with the majority belonging to the Lecanorales order 1 . The Parmeliaceae family has been particularly well-studied, with 22 species successfully cultured 1 .
Species Successfully Cultivated
Instead of harvesting wild lichens, valuable compounds could be produced through controlled cultivation.
Laboratory cultivation provides a reliable supply for screening and developing new pharmaceuticals.
Understanding how and why these compounds are produced could lead to bioengineering approaches.
Reducing pressure on wild lichen populations while still accessing their chemical wealth.
As research continues, scientists are refining their methods for lichen cultivation. The advent of genomic technologies has identified biosynthetic gene clusters (BGCs) responsible for producing compounds like atranorin, usnic acid, and grayanic acid 1 . This genetic information provides new targets for manipulating and optimizing metabolite production.
Recent advances in epigenetic manipulation—such as modifying histone deacetylase activity—have shown promise in activating silent biosynthetic gene clusters in fungi 9 . Similar approaches could potentially be applied to lichen-forming ascomycetes to unlock new metabolic pathways.
The development of efficient lichen culture systems represents more than just a technical achievement—it opens a door to understanding and utilizing some of nature's most complex symbiotic relationships and the valuable chemical compounds they produce.
The journey to cultivate lichens in the laboratory has been challenging, but recent advances in understanding morphogenetic strategies and inducing secondary metabolite biosynthesis are yielding exciting results. By studying model species like Pulchrocladia retipora and Dactylina arctica, scientists are gradually unlocking the secrets of how these remarkable organisms produce their valuable chemical arsenals.
As cultivation methods continue to improve, we move closer to harnessing the full potential of lichens as sources of medicines, biochemicals, and scientific insights—all while protecting the natural populations that have inspired this research. The humble lichen, once simply a curiosity of nature, may well hold keys to addressing some of our most pressing medical challenges.